95
76
Growth Score
8 pts
Heat Score
52 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36464
Coiled Therapeutics is a clinical-stage precision oncology company dedicated to developing the next generation of cancer therapeutics.
- Simon Sinclair: NED
- Darrin Disley: Interim MD and DirectorPast Role: Mogrify, CEO, Director & Investor
About the Company
Coiled Therapeutics is a clinical-stage precision oncology company dedicated to developing the next generation of cancer therapeutics by targeting historically difficult-to-drug proteins, particularly coiled-coil and structurally complex oncogenic targets.
Roquefort Therapeutics was founded in 2020 and was headquartered in London.
